Omnicell Investor Presentation Deck

Reconciliation of GAAP net income (loss) to non-GAAP EBITDA (¹): GAAP net income (loss) Share-based compensation expense Interest (income) and expense, net Depreciation and amortization expense Acquisition accounting impact related to deferred revenues Omnicell, Inc. Reconciliation of GAAP to Non-GAAP (Unaudited, in thousands, except per share data and percentage) Acquisition-related expenses Impairment and abandonment of operating lease right-of-use and other assets related to facilities Ransomware-related expenses, net of insurance recoveries © 2023 Omnicell, Inc. Three Months Ended June 30, 2023 $ 3,451 14,089 (4,410) 22,080 246 Three Months Ended March 31, 2023 $ (15,000) $ 14,042 (3,074) 21,974 246 8,420 Three Months Ended December 31, 2022 5,314 1,045 (6,182) 26,785 (28,408) $ 17,516 (2,410) 22,088 Executives transition costs 841 Severance-related and other expenses 721 Amortization of debt issuance costs 1,046 Provision for (benefit from) income taxes Non-GAAP EBITDA 8,758 46,822 $ $ $ (a) Defined as earnings before interest income and expense, taxes, depreciation, amortization, and share-based compensation, as well as excluding certain other non-GAAP adjustments. Three Months Ended September 30, 2022 40 246 3,992 73 18,782 1,043 (7,106) 25,856 $ 16,774 17,310 (1,136) 21,826 183 251 297 1,027 2,494 1,042 543 60,611 Year Ended December 31, 2017 $ $ 30,518 21,857 6,072 51,511 1,252 1,715 25 4,752 (26,006) 91,671

View entire presentation